A Randomized Trial Comparing Combined Basal Insulin/Glargine and Exenatide Therapy (BET) with Combined Basal Insulin/Glargine and Bolus Insulin/Humalog Lispro Therapy (BBT) in Subjects with Type 2 Diabetes, Being Treated by Glargine with Metformin Alone or with Combination of Metformin with Sulfonylurea.
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Exenatide; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Dec 2011 Status changed from recruiting to active, no longer recruiting as reported by UKCRN.
- 26 Feb 2010 New trial record